Skip to main content

Peer Review reports

From: Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Original Submission
20 Feb 2022 Submitted Original manuscript
14 Apr 2022 Reviewed Reviewer Report
25 May 2022 Reviewed Reviewer Report
22 Jun 2022 Author responded Author comments - Xiaorong Wu
Resubmission - Version 2
22 Jun 2022 Submitted Manuscript version 2
25 Jun 2022 Reviewed Reviewer Report
4 Jul 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
6 Jul 2022 Editorially accepted
18 Jul 2022 Article published 10.1186/s12894-022-01060-1

You can find further information about peer review here.

Back to article page